Exact Sciences Corp (EXAS)

Feb 21, 2025

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Benzinga

Feb 21, 2025

Feb 20, 2025

Exact Sciences Corp Earnings Call Highlights Growth - TipRanks

Feb 20, 2025

Feb 20, 2025

Exact Sciences Has an Established Colon Cancer Screening Franchise and a Progressing Pipeline - Morningstar

Feb 20, 2025

Feb 20, 2025

Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts - Benzinga

Feb 20, 2025

Feb 20, 2025

TD Cowen sees upside in Exact Sciences stock, maintains $86 target - Investing.com

Feb 20, 2025

Feb 20, 2025

Exact Sciences stock price target cut to $65 at BTIG - Investing.com

Feb 20, 2025

Feb 20, 2025

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

Feb 20, 2025

Exact Sciences stock price target cut to $65 at BTIG By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

Exact Sciences Reports Robust Q4 Earnings, Surpassing Revenue ProjectionsNews and Statistics - IndexBox, Inc.

Feb 20, 2025

Feb 20, 2025

Exact Sciences (EXAS) PT Lowered to $65 at BTIG - StreetInsider.com

Feb 20, 2025

Feb 20, 2025

Exact Sciences: Q4 Earnings Snapshot - mySA

Feb 20, 2025

Feb 20, 2025

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Str - GuruFocus.com

Feb 20, 2025

Feb 20, 2025

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Exact Sciences Reports Strong Revenue Growth in 2024 - TipRanks

Feb 19, 2025

Feb 19, 2025

Exact Sciences 2025 revenue guidance range includes consensus - MSN

Feb 19, 2025

Feb 19, 2025

Exact Sciences Announces Fourth Quarter 2024 Results - BioSpace

Feb 19, 2025

Feb 19, 2025

Exact Sciences Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 19, 2025

Feb 19, 2025

EXACT SCIENCES Earnings Results: $EXAS Reports Quarterly Earnings - Nasdaq

Feb 19, 2025

Feb 19, 2025

Exact Sciences Corp Plans To Launch Three New Cancer Tests In 2025 -February 19, 2025 at 05:44 pm EST - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

EXACT SCIENCES CORP SEC 10-K Report - TradingView

Feb 19, 2025

Feb 19, 2025

Exact Sciences Stock Slides On Q4 Earnings: The Details - Benzinga

Feb 19, 2025

Feb 19, 2025

Exact Sciences stock falls despite Q4 earnings beat By Investing.com - Investing.com Australia

Feb 19, 2025

Feb 19, 2025

Exact Sciences stock falls despite Q4 earnings beat - Investing.com

Feb 19, 2025

Feb 19, 2025

Exact Sciences: Q4 Earnings Snapshot -February 19, 2025 at 04:43 pm EST - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Exact Sciences Q4 Net Loss Widens, Revenue Up; Sets Outlook -February 19, 2025 at 04:22 pm EST - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

EXACT Sciences earnings beat by $0.27, revenue topped estimates - Investing.com

Feb 19, 2025

Feb 19, 2025

Exact Sciences Corp. Reports Fourth Quarter and Full Year 2024 Results - TradingView

Feb 19, 2025

Feb 18, 2025

U.S. Patent Trial and Appeal Board Institutes Inter Partes Review Based on Geneoscopy’s Petition Challenging Validity of a Second Patent Asserted by Exact Sciences - Business Wire

Feb 18, 2025

Feb 15, 2025

Banque Pictet & Cie SA Has $3.97 Million Stake in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 15, 2025

Feb 14, 2025

Exact Sciences (EXAS) Projected to Post Earnings on Wednesday - MarketBeat

Feb 14, 2025

Feb 14, 2025

8,508 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors - MarketBeat

Feb 14, 2025

Feb 14, 2025

Barclays sets Exact Sciences stock price target at $70 with Overweight rating - MSN

Feb 14, 2025

Feb 14, 2025

abrdn plc Grows Stock Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 14, 2025

Feb 14, 2025

Sumitomo Mitsui Trust Group Inc. Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 14, 2025

Feb 13, 2025

EULAV Asset Management Sells 20,000 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 13, 2025

Feb 12, 2025

Thompson Investment Management Inc. Buys 36,505 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 12, 2025

Feb 10, 2025

When Can We Expect A Profit From Exact Sciences Corporation (NASDAQ:EXAS)? - Yahoo Finance

Feb 10, 2025

Feb 09, 2025

Exact Sciences Co. (NASDAQ:EXAS) Position Cut by Jennison Associates LLC - MarketBeat

Feb 09, 2025

Feb 08, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat

Feb 08, 2025

Feb 06, 2025

Swedbank AB Buys 13,333 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 06, 2025

Feb 05, 2025

Exact Sciences Co. (NASDAQ:EXAS) Receives $72.76 Average Price Target from Brokerages - MarketBeat

Feb 05, 2025

Feb 05, 2025

Flatiron Health and Exact Sciences Partner to Advance Clinical Evidence Generation for Molecular Residual Disease Testing - BioSpace

Feb 05, 2025

Feb 04, 2025

Blue Trust Inc. Reduces Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Feb 04, 2025

Feb 04, 2025

Exact Sciences Co. (NASDAQ:EXAS) Stake Boosted by Chicago Capital LLC - MarketBeat

Feb 04, 2025

Feb 04, 2025

Gagnon Securities LLC Has $13.83 Million Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 04, 2025

Feb 03, 2025

Exact Sciences' Cologuard gets FDA committee nod - WiscNews

Feb 03, 2025

Feb 03, 2025

Exact Sciences Schedules Fourth Quarter 2024 Earnings Call - BioSpace

Feb 03, 2025

Feb 03, 2025

Earnings Alert: Exact Sciences Q4 2024 Results Coming February 19What Wall Street Is Watching - StockTitan

Feb 03, 2025

Feb 02, 2025

77,053 Shares in Exact Sciences Co. (NASDAQ:EXAS) Purchased by Baader Bank Aktiengesellschaft - MarketBeat

Feb 02, 2025

Feb 02, 2025

Barclays Initiates Coverage of Exact Sciences (EXAS) with Overweight Recommendation - MSN

Feb 02, 2025

Feb 02, 2025

Exact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 02, 2025